Home › Ulcerative Colitis › Washington › Tacoma
Ulcerative Colitis clinical trials in Tacoma, WA
13 studies for Ulcerative Colitis are looking for participants at sites in and around Tacoma (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 2
- Site US-029, Tacoma
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
RecruitingPhase 2
- Digestive Health Specialists, Tacoma
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
RecruitingPhase 3
- Washington Gastroenterology - Tacoma ( Site 0295), Tacoma
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 2
- Washington Gastroenterology - Tacoma, Tacoma
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
RecruitingPhase 3
- Washington Gastroenterology - Tacoma, Tacoma
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 3
- GI Alliance Tacoma, Tacoma
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
RecruitingPhase 2
- Washington Gastroenterology - Tacoma /ID# 284143, Tacoma
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
RecruitingPhase 2
- Site 019, Tacoma
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
RecruitingObservational study
- Washington Gastroenterology, Tacoma
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
RecruitingPhase 2/3
- MultiCare Health System, Tacoma
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
RecruitingPhase 3
- Multicare Health System Institute for Research and Innovation, Tacoma
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
RecruitingPhase 3
- MultiCare Institute for Research & Innovation, Tacoma
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
RecruitingPhase 2
- Mirador Therapeutics Selected Site, Tacoma
About Ulcerative Colitis
Ulcerative Colitis (UC) can cause long-lasting swelling and ulcers in the large intestine. It is a type of inflammatory bowel disease. Find out more.
More about Ulcerative Colitis on MedlinePlus
Ulcerative Colitis trials in other cities
- Orlando, FL21 studies
- New York City, NY21 studies
- Miami, FL20 studies
- Houston, TX14 studies
- San Diego, CA13 studies
- Chicago, IL13 studies
- St. Louis, MO13 studies
- Tyler, TX13 studies
- San Antonio, TX13 studies
- Colorado Springs, CO12 studies
- Boston, MA12 studies
- Los Angeles, CA11 studies
Other studies in Tacoma
- Non-Small Cell Lung Cancer18 studies
- Breast Cancer17 studies
- Multiple Myeloma13 studies
- Prostate Cancer11 studies
- Metastatic Cancer10 studies
- Crohn's Disease10 studies
- Colorectal Cancer10 studies
- Ovarian Cancer7 studies
- Melanoma7 studies
- Cancer (all types)6 studies
- Stomach Cancer6 studies
- Pancreatic Cancer6 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.